Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis

Cytokine and Growth Factor Reviews

Volumn 19, Issue 5-6, 2008, Pages 395-404

  Weber, Friedemann ^a   Mirazimi, Ali ^b,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

CCHFv; Crimean Congo Hemorrhagic fever virus; Cytokines; Interferons; Pathogenesis

Indexed keywords

CYTOKINE; INTERFERON; LIVER ENZYME;

CLINICAL FEATURE; HOST PATHOGEN INTERACTION; HUMAN; INNATE IMMUNITY; NAIRO VIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; REVIEW; ZOONOSIS;

CYTOKINES; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; INTERFERON TYPE I; INTERFERONS; SIGNAL TRANSDUCTION;

CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS;

EID: 56949088216     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2008.11.001     Document Type: Review

References (122)

1. Nichol S. Bunyaviruses. In: Knipe D., and Howley P. (Eds). Fields virology (2001), Lippincott Williams and Wilkins, Philadelpia 1603-1633
2. Elliott R.M. In: Elliott R.M. (Ed). The Bunyaviridae (1996), Plenum Press, New York
3. Elliott R.M., Schmaljohn C.S., and Collett M.S. Bunyaviridae genome structure and gene expression. Curr Top Microbiol Immunol 169 (1991) 91-141
4. Blakqori G., Delhaye S., Habjan M., Blair C.D., Sánchez-Vargas I., Olson K.E., et al. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol. 81 10 (2007 May) 4991-4999
5. Le May N., Dubaele S., Proietti De Santis L., Billecocq A., Bouloy M., and Egly J.M. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116 4 (2004) 541-550
6. Kormelink R., Kitajima E.W., De Haan P., Zuidema D., Peters D., and Goldbach R. The nonstructural protein (NSs) encoded by the ambisense S RNA segment of tomato spotted wilt virus is associated with fibrous structures in infected plant cells. Virology 181 2 (1991) 459-468
7. Fuller F., Bhown A.S., and Bishop D.H. Bunyavirus nucleoprotein, N, and a non-structural protein, NSS, are coded by overlapping reading frames in the S RNA. J Gen Virol 64 Pt 8 (1983) 1705-1714
8. Jääskeläinen K.M., Kaukinen P., Minskaya E.S., Plyusnina A., Vapalahti O., Elliott R.M., et al. Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter. J Med Virol 79 10 (2007) 1527-1536
9. Bergeron E., Vincent M.J., and Nichol S.T. Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1/S1P is critical for virus infectivity. J Virol 81 23 (2007) 13271-13276
10. Fontana J., López-Montero N., Elliott R.M., Fernández J.J., and Risco C. The unique architecture of Bunyamwera virus factories around the Golgi complex. Cell Microbiol (2008)
11. Altamura L.A., Bertolotti-Ciarlet A., Teigler J., Paragas J., Schmaljohn C.S., and Doms R.W. Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreGN that leads to generation of an NSM protein. J Virol 81 12 (2007) 6632-6642
12. Pollitt E., Zhao J., Muscat P., and Elliott R.M. Characterization of Maguari orthobunyavirus mutants suggests the nonstructural protein NSm is not essential for growth in tissue culture. Virology 348 1 (2006) 224-232
13. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6 4 (2006) 203-214
14. Dunster L., Dunster M., Ofula V., Beti D., Kazooba-Voskamp F., Burt F., et al. First documentation of human Crimean-Congo hemorrhagic fever, Kenya. Emerg Infect Dis 8 9 (2002) 1005-1006
15. Drosten C., Minnak D., Emmerich P., Schmitz H., and Reinicke T. Crimean-Congo hemorrhagic fever in Kosovo. J Clin Microbiol 40 3 (2002) 1122-1123
16. Nabeth P., Thior M., Faye O., and Simon F. Human Crimean-Congo hemorrhagic fever, Senegal. Emerg Infect Dis 10 10 (2004) 1881-1882
17. Nabeth P., Cheikh D.O., Lo B., Faye O., Vall I.O., Niang M., et al. Crimean-Congo hemorrhagic fever, Mauritania. Emerg Infect Dis 10 12 (2004) 2143-2149
18. el-Azazy O.M., and Scrimgeour E.M. Crimean-Congo haemorrhagic fever virus infection in the western province of Saudi Arabia. Trans R Soc Trop Med Hyg 91 3 (1997) 275-278
19. Williams R.J., Al-Busaidy S., Mehta F.R., Maupin G.O., Wagoner K.D., Al-Awaidy S., et al. Crimean-congo haemorrhagic fever: a seroepidemiological and tick survey in the Sultanate of Oman. Trop Med Int Health 5 2 (2000) 99-106
20. Burney M.I., Ghafoor A., Saleen M., Webb P.A., and Casals J. Nosocomial outbreak of viral hemorrhagic fever caused by Crimean Hemorrhagic fever-Congo virus in Pakistan, January 1976. Am J Trop Med Hyg 29 5 (1980) 941-947
21. Papa A., Bino S., Llagami A., Brahimaj B., Papadimitriou E., Pavlidou V., et al. Crimean-Congo hemorrhagic fever in Albania, 2001. Eur J Clin Microbiol Infect Dis 21 8 (2002) 603-606
22. Papa A., Christova I., Papadimitriou E., and Antoniadis A. Crimean-Congo hemorrhagic fever in Bulgaria. Emerg Infect Dis 10 8 (2004) 1465-1467
23. Sheikh A.S., Sheikh A.A., Sheikh N.S., Rafi-U-Shan, Asif M., Afridi F., et al. Bi-annual surge of Crimean-Congo haemorrhagic fever (CCHF): a five-year experience. Int J Infect Dis 9 1 (2005) 37-42
24. Papa A., Ma B., Kouidou S., Tang Q., Hang C., and Antoniadis A. Genetic characterization of the M RNA segment of Crimean Congo hemorrhagic fever virus strains, China. Emerg Infect Dis 8 1 (2002) 50-53
25. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol 15 4 (1979) 307-417
26. Watts D.M., Kziasek T.G., Linthicum K.J., and Hoogstraal H. Crimean congo hemorrahgic fever. In: Monath T.P. (Ed). The arboviruses: epidemiology and ecology (1988), CRC Press, Boca Raton, Fl, USA 177260
27. van de Wal B.W., Joubert J.R., van Eeden P.J., and King J.B. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part IV. Preventive and prophylactic measures. S Afr Med J 68 10 (1985) 729-732
28. van Eeden P.J., Joubert J.R., van de Wal B.W., King J.B., de Kock A., and Groenewald J.H. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part II. Management of patients. S Afr Med J 68 10 (1985) 718-721
29. Swanepoel R., Shepherd A.J., Leman P.A., and Shepherd S.P. Investigations following initial recognition of Crimean-Congo haemorrhagic fever in South Africa and the diagnosis of 2 further cases. S Afr Med J 68 9 (1985) 638-641
30. Chinikar S., Persson S.M., Johansson M., Bladh L., Goya M., Houshmand B., et al. Genetic analysis of Crimean-Congo hemorrhagic fever virus in Iran. J Med Virol 73 3 (2004) 404-411
31. Swanepoel R., Gill D.E., Shepherd A.J., Leman P.A., Mynhardt J.H., and Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 11 Suppl 4 (1989) S794-S800
32. Schwarz T.F., Nsanze H., and Ameen A.M. Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates. Infection 25 6 (1997) 364-367
33. Baskerville A., Satti A., Murphy F.A., and Simpson D.I. Congo-Crimean haemorrhagic fever in Dubai: histopathological studies. J Clin Pathol 34 8 (1981) 871-874
34. Wölfel R., Paweska J.T., Petersen N., Grobbelaar A.A., Leman P.A., Hewson R., et al. Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis 13 7 (2007) 1097-1100
35. Duh D., Saksida A., Petrovec M., Ahmeti S., Dedushaj I., Panning M., et al. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg Infect Dis 13 11 (2007) 1769-1772
36. Yilmaz M., Aydin K., Akdogan E., Sucu N., Sonmez M., Omay S.B., et al. Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever. J Clin Virol 42 4 (2008) 415-417
37. Celikbaş A., Ergönül O., Dokuzoǧuz B., Eren S., Baykam N., and Polat-Düzgün A. Crimean Congo hemorrhagic fever infection simulating acute appendicitis. J Infect 50 4 (2005) 363-365
38. Ergonul O., Tuncbilek S., Baykam N., Celikbas A., and Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 193 7 (2006) 941-944
39. Onguru P., Akgul E.O., Akinci E., Yaman H., Kurt Y.G., Erbay A., et al. High serum levels of neopterin in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J Infect 56 5 (2008) 366-370
40. Ozkurt Z., Kiki I., Erol S., Erdem F., Yilmaz N., Parlak M., et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect (2005)
41. Haller O., Kochs G., and Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344 1 (2006) 119-130
42. Samuel C.E. Antiviral actions of interferons. Clin Microbiol Rev 14 4 (2001) 778-809 table of contents
43. Sadler A.J., and Williams B.R. Interferon-inducible antiviral effectors. Nat Rev Immunol 8 7 (2008) 559-568
44. Hertzog P.J., O'Neill L.A., and Hamilton J.A. The interferon in TLR signaling: more than just antiviral. Trends Immunol 24 10 (2003) 534-539
45. Le Bon A., and Tough D.F. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 14 4 (2002) 432-436
46. van Pesch V., and Michiels T. Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. J Biol Chem 278 47 (2003) 46321-46328
47. van Pesch V., Lanaya H., Renauld J.C., and Michiels T. Characterization of the murine alpha interferon gene family. J Virol 78 15 (2004) 8219-8228
48. Roberts R.M., Ezashi T., Rosenfeld C.S., Ealy A.D., and Kubisch H.M. Evolution of the interferon tau genes and their promoters, and maternal-trophoblast interactions in control of their expression. Reprod Suppl 61 (2003) 239-251
49. Delhaye S., Paul S., Blakqori G., Minet M., Weber F., Staeheli P., et al. Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci USA 103 20 (2006) 7835-7840
50. Marie I., Durbin J.E., and Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. Embo J 17 22 (1998) 6660-6669
51. Colonna M., Krug A., and Cella M. Interferon-producing cells: on the front line in immune responses against pathogens. Curr Opin Immunol 14 3 (2002) 373-379
52. Weber F., Wagner V., Rasmussen S.B., Hartmann R., and Paludan S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 80 10 (2006) 5059-5064
53. Hornung V., Ellegast J., Kim S., Brzózka K., Jung A., Kato H., et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314 5801 (2006) 994-997
54. Pichlmair A., Schulz O., Tan C.P., Näslund T.I., Liljeström P., Weber F., et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314 5801 (2006) 997-1001
55. Plumet S., Herschke F., Bourhis J.M., Valentin H., Longhi S., and Gerlier D. Cytosolic 5′-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS ONE 2 3 (2007) e279
56. Yoneyama M., Onomoto K., and Fujita T. Cytoplasmic recognition of RNA. Adv Drug Deliv Rev 60 7 (2008) 841-846
57. Pichlmair A., and Reis e Sousa C. Innate recognition of viruses. Immunity 27 3 (2007) 370-383
58. Randall R.E., and Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89 Pt 1 (2008) 1-47
59. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 7089 (2006) 101-105
60. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205 7 (2008) 1601-1610
61. Hiscott J. Triggering the innate antiviral response through IRF-3 activation. J Biol Chem 282 21 (2007) 15325-15329
62. Paun A., and Pitha P.M. The IRF family, revisited. Biochimie 89 6-7 (2007) 744-753
63. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13 4 (2000) 539-548
64. Chu W.M., Ostertag D., Li Z.W., Chang L., Chen Y., Hu Y., Williams B., et al. JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 11 6 (1999) 721-731
65. Escalante C.R., Shen L., Thanos D., and Aggarwal A.K. Structure of NF-kappaB p50/p65 heterodimer bound to the PRDII DNA element from the interferon-beta promoter. Structure 10 3 (2002) 383-391
66. Diebold S.S., Montoya M., Unger H., Alexopoulou L., Roy P., Haswell L.E., et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424 6946 (2003) 324-328
67. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 6857 (2001) 732-738
68. Uematsu S., and Akira S. Toll-like receptor and innate immunity. Seikagaku 79 8 (2007) 769-776
69. de Weerd N.A., Samarajiwa S.A., and Hertzog P.J. Type I interferon receptors: biochemistry and biological functions. J Biol Chem 282 28 (2007) 20053-20057
70. Schindler C., Levy D.E., and Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem 282 28 (2007) 20059-20063
71. Levy D.E., and Darnell Jr. J.E. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3 9 (2002) 651-662
72. Der S.D., Zhou A., Williams B.R., and Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 95 26 (1998) 15623-15628
73. Haller O., Staeheli P., and Kochs G. Interferon-induced Mx proteins in antiviral host defense. Biochimie 89 6-7 (2007) 812-818
74. Haller O., Kochs G., and Weber F. Interferon, Mx, and viral countermeasures. Cytokine Growth Factor Rev 18 5-6 (2007) 425-433
75. Nallagatla S.R., Hwang J., Toroney R., Zheng X., Cameron C.E., and Bevilacqua P.C. 5′-triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science 318 5855 (2007) 1455-1458
76. Garcia M.A., Meurs E.F., and Esteban M. The dsRNA protein kinase PKR: virus and cell control. Biochimie 89 6-7 (2007) 799-811
77. Hovanessian A.G., and Justesen J. The human 2′-5′oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation. Biochimie 89 6-7 (2007) 779-788
78. Bisbal C., and Silverman R.H. Diverse functions of RNase L and implications in pathology. Biochimie 89 6-7 (2007) 789-798
79. Chin K.C., and Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci USA 98 26 (2001) 15125-15130
80. Wang X., Hinson E.R., and Cresswell P. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2 2 (2007) 96-105
81. Sen G.C., and Peters G.A. Viral stress-inducible genes. Adv Virus Res 70 (2007) 233-263
82. Degols G., Eldin P., and Mechti N. ISG20, an actor of the innate immune response. Biochimie 89 6-7 (2007) 831-835
83. Shresta S., Kyle J.L., Snider H.M., Basavapatna M., Beatty P.R., and Harris E. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol 78 6 (2004) 2701-2710
84. Bray M., and Geisbert T.W. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 37 8 (2005) 1560-1566
85. Bray M. Pathogenesis of viral hemorrhagic fever. Curr Opin Immunol 17 4 (2005) 399-403
86. Navarro-Sanchez E., Despres P., and Cedillo-Barron L. Innate immune responses to dengue virus. Arch Med Res 36 5 (2005) 425-435
87. Baize S., Pannetier D., Faure C., Marianneau P., Marendat I., Georges-Courbot M.C., et al. Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages. Microbes Infect 8 5 (2006) 1194-1202
88. Summerfield A., Alves M., Ruggli N., de Bruin M.G., and McCullough K.C. High IFN-alpha responses associated with depletion of lymphocytes and natural IFN-producing cells during classical swine fever. J Interferon Cytokine Res 26 4 (2006) 248-255
89. Hutchinson K.L., and Rollin P.E. Cytokine and chemokine expression in humans infected with Sudan Ebola virus. J Infect Dis 196 Suppl 2 (2007) S357-S363
90. Bray M., and Pilch R. Filoviruses: recent advances and future challenges. Expert Rev Anti Infect Ther 4 6 (2006) 917-921
91. Andersson I., Lundkvist A., Haller O., and Mirazimi A. Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells. J Med Virol 78 2 (2006) 216-222
92. Bridgen A., Dalrymple D.A., Weber F., and Elliott R.M. Inhibition of Dugbe nairovirus replication by human MxA protein. Virus Res 99 1 (2004) 47-50
93. Frese M., Kochs G., Feldmann H., Hertkorn C., and Haller O. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J Virol 70 2 (1996) 915-923
94. Kanerva M., Melén K., Vaheri A., and Julkunen I. Inhibition of puumala and tula hantaviruses in Vero cells by MxA protein. Virology 224 1 (1996) 55-62
95. Sandrock M., Frese M., Haller O., and Kochs G. Interferon-induced rat Mx proteins confer resistance to Rift Valley fever virus and other arthropod-borne viruses. J Interferon Cytokine Res 21 9 (2001) 663-668
96. Andersson I., Lundkvist A., Haller O., and Mirazimi A. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J Virol 78 8 (2004) 4323-4329
97. Kochs G., Janzen C., Hohenberg H., and Haller O. Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc Natl Acad Sci USA 99 5 (2002) 3153-3158
98. Reichelt M., Stertz S., Krijnse-Locker J., Haller O., and Kochs G. Missorting of LaCrosse virus nucleocapsid protein by the interferon-induced MxA GTPase involves smooth ER membranes. Traffic 5 10 (2004) 772-784
99. Whitehouse C.A. Crimean-Congo hemorrhagic fever. Antiviral Res 64 3 (2004) 145-160
100. Andersson I., Karlberg H., Mousavi-Jazi M., Martínez-Sobrido L., Weber F., and Mirazimi A. Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response. J Med Virol 80 8 (2008) 1397-1404
101. Habjan M., Andersson I., Klingström J., Schümann M., Martin A., Zimmermann P., et al. Processing of genome 5′ termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 3 4 (2008) e2032
102. Billecocq A., Spiegel M., Vialat P., Kohl A., Weber F., Bouloy M., et al. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 78 18 (2004) 9798-9806
103. Bouloy M., Janzen C., Vialat P., Khun H., Pavlovic J., Huerre M., et al. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 75 3 (2001) 1371-1377
104. Garcin D., Lezzi M., Dobbs M., Elliott R.M., Schmaljohn C., Kang C.Y., et al. The 5′ ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. J Virol 69 9 (1995) 5754-5762
105. Collins S.E., Noyce R.S., and Mossman K.L. Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 78 4 (2004) 1706-1717
106. Paladino P., Cummings D.T., Noyce R.S., and Mossman K.L. The IFN-independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. J Immunol 177 11 (2006) 8008-8016
107. Frias-Staheli N., Giannakopoulos N.V., Kikkert M., Taylor S.L., Bridgen A., Paragas J., et al. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2 6 (2007) 404-416
108. Schnittler H.J., and Feldmann H. Viral hemorrhagic fever - a vascular disease?. Thromb Haemost 89 6 (2003) 967-972
109. Connolly-Andersen A.M., Magnusson K.E., and Mirazimi A. Basolateral entry and release of Crimean-Congo hemorrhagic fever virus in polarized MDCK-1 cells. J Virol 81 5 (2007) 2158-2164
110. Chen S.T., Lin Y.L., Huang M.T., Wu M.F., Cheng S.C., Lei H.Y., et al. CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453 7195 (2008) 672-676
111. Chen H.C., Hofman F.M., Kung J.T., Lin Y.D., and Wu-Hsieh B.A. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 81 11 (2007) 5518-5526
112. Lei H.Y., Yeh T.M., Liu H.S., Lin Y.S., Chen S.H., and Liu C.C. Immunopathogenesis of dengue virus infection. J Biomed Sci 8 5 (2001) 377-388
113. ter Meulen J., Sakho M., Koulemou K., Magassouba N., Bah A., Preiser W., et al. Activation of the cytokine network and unfavorable outcome in patients with yellow fever. J Infect Dis 190 10 (2004) 1821-1827
114. Baize S., Leroy E.M., Georges A.J., Georges-Courbot M.C., Capron M., Bedjabaga I., et al. Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 128 1 (2002) 163-168
115. Papa A., Bino S., Velo E., Harxhi A., Kota M., and Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol 36 4 (2006) 272-276
116. Chan C.P., Choi J.W., Cao K.Y., Wang M., Gao Y., Zhou D.H., et al. Detection of serum neopterin for early assessment of dengue virus infection. J Infect 53 3 (2006) 152-158
117. Wirleitner B., Reider D., Ebner S., Böck G., Widner B., Jaeger M., et al. Monocyte-derived dendritic cells release neopterin. J Leukoc Biol 72 6 (2002) 1148-1153
118. Thomas D., Blakqori G., Wagner V., Banholzer M., Kessler N., Elliott R.M., et al. Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist. J Biol Chem 279 30 (2004) 31471-31477
119. Le May N., Mansuroglu Z., Léger P., Josse T., Blot G., Billecocq A., et al. A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog 4 1 (2008) e13
120. Jääskeläinen K.M., Plyusnina A., Lundkvist A., Vaheri A., and Plyusnin A. Tula hantavirus isolate with the full-length ORF for nonstructural protein NSs survives for more consequent passages in interferon-competent cells than the isolate having truncated NSs ORF. Virol J 5 (2008) 3
121. Alff P.J., Gavrilovskaya I.N., Gorbunova E., Endriss K., Chong Y., Geimonen E., et al. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol 80 19 (2006) 9676-9686
122. Spiropoulou C.F., Albariño C.G., Ksiazek T.G., and Rollin P.E. Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J Virol 81 6 (2007) 2769-2776